Gill S - Search Results

1

Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial.

Jonker DJ, Nott L, Yoshino T, Gill S, Shapiro J, Ohtsu A, Zalcberg J, Vickers MM, Wei AC, Gao Y, Tebbutt NC, Markman B, Price T, Esaki T, Koski S, Hitron M, Li W, Li Y, Magoski NM, Li CJ, Simes J, Tu D, O'Callaghan CJ. Jonker DJ, et al. Among authors: gill s. Lancet Gastroenterol Hepatol. 2018 Apr;3(4):263-270. doi: 10.1016/S2468-1253(18)30009-8. Epub 2018 Feb 1. Lancet Gastroenterol Hepatol. 2018. PMID: 29397354 Clinical Trial.

2

Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis.

Ho C, Ng K, O'Reilly S, Gill S. Ho C, et al. Among authors: gill s. Clin Colorectal Cancer. 2005 Nov;5(4):279-82. doi: 10.3816/ccc.2005.n.040. Clin Colorectal Cancer. 2005. PMID: 16356306

3

Colorectal cancer.

Gill S, Blackstock AW, Goldberg RM. Gill S, et al. Mayo Clin Proc. 2007 Jan;82(1):114-29. doi: 10.4065/82.1.114. Mayo Clin Proc. 2007. PMID: 17285793 Review.

4

Trends in chemotherapy utilization for colorectal cancer.

Renouf D, Kennecke H, Gill S. Renouf D, et al. Among authors: gill s. Clin Colorectal Cancer. 2008 Nov;7(6):386-9. doi: 10.3816/CCC.2008.n.051. Clin Colorectal Cancer. 2008. PMID: 19036691

5

The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group.

Courneya KS, Booth CM, Gill S, O'Brien P, Vardy J, Friedenreich CM, Au HJ, Brundage MD, Tu D, Dhillon H, Meyer RM. Courneya KS, et al. Among authors: gill s. Curr Oncol. 2008 Dec;15(6):279-85. doi: 10.3747/co.v15i6.378. Curr Oncol. 2008. PMID: 19079628 Free PMC article.

6

Primary tumor resection in patients presenting with metastatic colorectal cancer: analysis of a provincial population-based cohort.

Chan TW, Brown C, Ho CC, Gill S. Chan TW, et al. Among authors: gill s. Am J Clin Oncol. 2010 Feb;33(1):52-5. doi: 10.1097/COC.0b013e31819e902d. Am J Clin Oncol. 2010. PMID: 19704367

7

A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.

Renouf DJ, Moore MJ, Hedley D, Gill S, Jonker D, Chen E, Walde D, Goel R, Southwood B, Gauthier I, Walsh W, McIntosh L, Seymour L. Renouf DJ, et al. Among authors: gill s. Invest New Drugs. 2012 Apr;30(2):779-86. doi: 10.1007/s10637-010-9611-3. Epub 2010 Dec 18. Invest New Drugs. 2012. PMID: 21170669 Clinical Trial.

8

KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice.

Blanke CD, Goldberg RM, Grothey A, Mooney M, Roach N, Saltz LB, Welch JJ, Wood WA, Meropol NJ; NCI GI Steering Committee Colon Cancer Task Force. Blanke CD, et al. Oncologist. 2011;16(8):1061-8. doi: 10.1634/theoncologist.2011-0011. Epub 2011 Jul 7. Oncologist. 2011. PMID: 21737577 Free PMC article.

9

Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis.

Renouf DJ, Lim HJ, Speers C, Villa D, Gill S, Blanke CD, O'Reilly SE, Kennecke H. Renouf DJ, et al. Among authors: gill s. Clin Colorectal Cancer. 2011 Jun;10(2):97-101. doi: 10.1016/j.clcc.2011.03.004. Epub 2011 Apr 22. Clin Colorectal Cancer. 2011. PMID: 21859560

10

Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer.

Gill S, Berry S, Biagi J, Butts C, Buyse M, Chen E, Jonker D, Mărginean C, Samson B, Stewart J, Thirlwell M, Wong R, Maroun JA. Gill S, et al. Curr Oncol. 2011 Oct;18 Suppl 2(Suppl 2):S5-S10. doi: 10.3747/co.v18is2.941. Curr Oncol. 2011. PMID: 21969810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,661 results

Search Page

Filters